TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+1.76%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$128M
AUM Growth
+$128M
(-44%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-81.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
3
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$47.6M |
| 2 |
Pliant Therapeutics
PLRX
|
$38.7M |
| 3 |
Fulcrum Therapeutics
FULC
|
$14.6M |
| 4 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
$2.69M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$7.39B
| $38.2M | 29.95% |
1,604,130
-2,000,000
| -55% | -$47.6M |
|
|
2
Pliant Therapeutics
PLRX
$103M
| $35.6M | 27.86% |
1,839,160
-2,000,000
| -52% | -$38.7M |
|
3
Voyager Therapeutics
VYGR
$199M
| $33.1M | 25.95% |
5,428,933
| – | – |
|
|
4
Fulcrum Therapeutics
FULC
$347M
| $14.3M | 11.2% |
1,962,202
-2,000,000
| -50% | -$14.6M |
|
|
DBTX
5
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $6.44M | 5.04% |
3,139,685
| – | – |
|
|
JNCE
6
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-1,148,780
| Closed | -$2.69M |
|